Development and maintenance of regulatory T cells.

By Naganari Ohkura, Y. Kitagawa, Shimon Sakaguchi. Immunity, 2013

715 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/c77b7ee146d938b6196aea79fc2e1dde9ef92a82

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Shimon Sakaguchi
2. Atsushi Tanaka
3. J. Bluestone
4. Naganari Ohkura
5. J. Wing
6. K. Ichiyama
7. N. Mikami
8. Alexander Y. Rudensky

In Oncology

1. Atsushi Tanaka
2. Shimon Sakaguchi
3. J. Bluestone

Citations in the corpus

• Regulatory T Cells and Human Disease. (2020, background): “Logically, DNA demethylation at Treg-DRs is more accurate than these protein markers in defining functional Tregs because CpGmethylation/ demethylation is digital information capable of differentiating between Tregs and Tconvs via the mode of gene expression at Treg signature gene loci (36, 42).”
• CD28 costimulation: from mechanism to therapy (2016, background): “Treg cells provide dominant suppression of autoreactive T cells and are necessary to prevent autoimmune disease in mice and humans (Ohkura et al., 2013).”